Svetlana Sadyrbaeva-Dolgova

EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

Carmen Hidalgo‐Tenorio, Svetlana Sadyrbaeva-Dolgova, Andrés Enríquez‐Gómez et al. · International Journal of Antimicrobial Agents · 2023 · 36 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

Pharmacist recommendations for carbapenem de-escalation in urinary tract infection within an antimicrobial stewardship program

Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Alberto Jiménez-Morales et al. · Journal of Infection and Public Health · 2019 · 33 citations · Full text

Pharmacy, Hospital Pharmacy, Pharmacy Practice +17

Clinical outcomes of carbapenem de-escalation regardless of microbiological results: A propensity score analysis

Svetlana Sadyrbaeva-Dolgova, Pilar Aznarte-Padial, Juan Pasquau-Liaño et al. · International Journal of Infectious Diseases · 2019 · 17 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Incidence of nephrotoxicity associated with intravenous colistimethate sodium administration for the treatment of multidrug-resistant gram-negative bacterial infections

Svetlana Sadyrbaeva-Dolgova, Ricardo García-Fumero, Manuela Expósito Ruíz et al. · Scientific Reports · 2022 · 16 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

The Challenge of Bacteremia Treatment due to Non-Fermenting Gram-Negative Bacteria

Svetlana Sadyrbaeva-Dolgova, Juan Antonio Reguera, Carmen Hidalgo‐Tenorio · Microorganisms · 2023 · 10 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17